Interstitial Lung Disease
Conditions
Interventions
Healthy control group:None
Sponsors
No 2 People' Hospital Of Fuyang City
Eligibility
Sex/Gender
All
Age
80 Years to 18 Years
Inclusion criteria
Inclusion criteria: 1. ILD patients: HRCT has imaging manifestations of pulmonary interstitial lesions such as grid-like, honeycomb-shaped, ground-glass shadow, traction bronchiectasis, etc., which are jointly judged by the imaging department and respiratory physicians. Pulmonary ventilation function tests show restrictive ventilatory dysfunction and/or diffusion dysfunction, and the specific classification is further clarified according to the relevant examination results combined with the disease diagnosis and treatment guidelines. 2. Healthy control group: healthy adults, no previous malignant tumors, severe liver and kidney insufficiency, hematological and cardiovascular and cerebrovascular diseases; Chronic airway disease, interstitial lung disease, and other lung diseases such as tuberculosis, pneumothorax, pleural effusion, etc.
Exclusion criteria
Exclusion criteria: Patients with interstitial lung disease 1. Combined with malignant tumors, severe liver and kidney insufficiency, hematological and cardiovascular and cerebrovascular diseases; 2. Patients with chronic airway disease and other lung diseases such as tuberculosis, pneumothorax, and pleural effusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fractional exhaled nitric oxide;Pulmonary Function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Krebs von den Lungen-6;Surfactant Protein-D; | — |
Countries
China
Contacts
Public ContactYa Shen
No 2 People' Hospital Of Fuyang City
Outcome results
None listed